Autophagy is a vital cellular process whereby cells degrade their own damaged or redundant components—such as proteins and organelles—under stress conditions (e.g., nutrient deprivation, hypoxia, infection) to maintain homeostasis. This mechanism not only regulates cellular metabolism but is also closely implicated in neurodegenerative diseases, cancer, immune modulation, and ageing. In recent years, advances in molecular and cellular biology techniques have deepened our understanding of autophagy, establishing it as a prominent area of research within life sciences and medicine.
   

Ⅰ.Frontier Mechanism: The Double-Edged Sword Effect of Autophagy

(i) Molecular Regulation Network of Autophagy
The autophagy process is regulated by highly conserved signalling pathways, with its core mechanism involving the synergistic interaction of the ULK complex, VPS34 complex, and the ATG protein family:
ULK complex: Comprising ULK1/2, FIP200, ATG13, and others, it is responsible for sensing nutritional and energy states and initiating the formation of autophagosomes.
VPS34 complex I: Catalyses the generation of phosphatidylinositol-3-phosphate (PI3P), triggering autophagy recruitment via the fusion mechanism.
The ATG protein family: comprising the ATG5-ATG12 complex, LC3 (light chain 3 of microtubule-associated protein 1), and others, participates in the extension and closure of autophagosome membranes.
  (ii) The Double-edged Sword Effect of Autophagy: Protection and Damage Coexist
Tumor Suppression: In the early stages of tumorigenesis, autophagy suppresses malignant transformation by degrading mutated proteins and damaged organelles. For example, allelic loss of the BECN1 gene (encoding the beclin-1 protein) is associated with breast cancer development.
Tumor Promotion: In the late stages of tumors, autophagy provides energy and nutrients to cancer cells by degrading surplus components, thereby promoting their proliferation and drug resistance. For instance, the RAS oncogene adapts to hypoxic and nutrient-deprived environments through autophagy.
Selective Autophagy: Mitophagy and Pexophagy maintain cellular homeostasis by eliminating reactive oxygen species (ROS) and damaged organelles, though excessive autophagy may precipitate cell death.
  (iii) Autophagy and Disease: From Mechanisms to Therapeutic Targets
Neurodegenerative Diseases: In Alzheimer's disease, defective autophagy leads to the accumulation of amyloid precursor protein (APP); in Parkinson's disease, the aggregation of α-synuclein correlates with impaired autophagic function.
Cardiovascular Diseases: Following myocardial infarction, autophagy influences cardiac function by regulating myocardial cell injury and death; in atherosclerosis, autophagy participates in lipid metabolism and inflammatory regulation.
Inflammatory Diseases: Autophagy plays a role in the pathological processes of chronic obstructive pulmonary disease, infection, and sepsis by regulating immune cell activity and antigen presentation.
 

II. Popular Areas

Autophagy research encompasses a broad spectrum of fields, spanning from fundamental biological mechanisms to clinical applications. The following outlines several key research directions:

(i) The Relationship Between Autophagy and Disease
Autophagy is closely implicated in the onset and progression of numerous diseases. Within oncology, autophagy can both promote tumour cell survival and inhibit tumourigenesis. For instance, autophagy can eliminate damaged mitochondria within cells, thereby reducing the production of reactive oxygen species (ROS) and suppressing tumour development. However, under certain circumstances, autophagy may also aid tumour cells in surviving adverse environments such as hypoxia, thereby facilitating tumour progression.
In neurodegenerative diseases, the role of autophagy has likewise attracted considerable attention. For instance, in Parkinson's disease, autophagy can clear intracellular α-synuclein aggregates, thereby mitigating neuronal damage. Furthermore, autophagy plays a significant role in conditions such as Alzheimer's disease and amyotrophic lateral sclerosis.

(ii) Regulatory Mechanisms of Autophagy
The research on autophagy regulatory mechanisms is a current hot topic. In addition to the mTOR signalling pathway and the Beclin-1 complex, epigenetic mechanisms also play a significant role in autophagy regulation. For example, certain microRNAs can modulate autophagy activity by targeting autophagy-related genes. Furthermore, intracellular oxidative stress states and energy metabolism also influence autophagy regulation.

(iii) The Intersection of Autophagy with Other Cellular Processes
Autophagy is not an isolated cellular process; it exhibits complex interactions with other cellular processes such as apoptosis and the cell cycle. For instance, during apoptosis, autophagy may synergise with apoptotic mechanisms to promote cell death. Furthermore, autophagy participates in cellular immune responses, regulating the activation and function of immune cells.
 

III. Recommended Cellular Autophagy-Related Detection Markers

Autophagy is a highly dynamic and multi-level regulated process involving numerous molecular signaling pathways and functional proteins. From autophagosome formation and substrate recognition to final lysosomal degradation, each step relies on the precise regulation of specific proteins. These molecules not only serve as markers of autophagic activity but are also closely associated with the onset and progression of various diseases. The following summarizes key detection indicators and their functions, providing reference for experimental design.
 
 

Target	Function	Role
LC3	Autophagy membrane marker proteins	An increase in the LC3-II/LC3-I ratio typically indicates elevated autophagy levels and may serve as a marker for autophagy activation.
p62（SQSTM1）	Autophagic target proteins	The degradation of p62 protein reflects the integrity of the autophagic flux, with its intracellular accumulation being negatively correlated with the integrity of the autophagic flux.
Beclin-1	Core components of the autophagy initiation complex	Participates in the formation of autophagosomes, playing a crucial role in the initiation phase of autophagy.
Atg5	Key proteins in the formation of autophagosomes	Forms a complex with Atg12, participating in the extension and closure of autophagosome membranes.
mTOR	Negative regulatory factors of autophagy	As a sensor of intracellular nutritional and energy status, the mTOR signalling pathway inhibits autophagy when activated and activates autophagy when inhibited.
AMPK	Positive regulatory factors of autophagy	Sense the energy state within cells, when cellular energy levels are low, AMPK is activated, thereby triggering autophagy.
ROS	Regulatory factors of autophagy	Moderate levels of reactive oxygen species (ROS) can induce autophagy, thereby maintaining intracellular redox balance; excessive ROS, however, may damage cells, activating autophagy to clear damaged components.

 

IV. Product Recommendation: Precision Testing for Research Decision Making

In the detection of autophagy-related markers, the ELISA Kit has become the preferred tool in scientific research due to its high sensitivity, high specificity, and ease of operation. Our cytokine ELISA Kits offer the following significant advantages:

1. High sensitivity: high-quality antibody and optimised reaction system are used to ensure the accuracy of results.
2. Wide applicability: suitable for serum, plasma, cell culture supernatants and other sample types to meet diversified testing needs.
3. Easy to operate: ready-to-use reagents, no need for complex preparation, standardised experimental process, saving time and cost.
4. Reliable quality: After strict quality control and validation, it ensures that inter-batch and intra-batch differences are minimised and results are stable and reliable.

 

Recommended Products:

JL46174   Human MAP1LC3(LC3) ELISA Kit

JL10996   Human Microtubule-associated Protein Light Chain 3B(LC3B) ELISA Kit

JL35198   Human Sequestosome 1 (SQSTM1) ELISA Kit

JL19973   Human Autophagy Related Protein 5 (ATG5) ELISA Kit

JL45984   Human Adenosine Monophosphate Activated Protein Kinase(AMPK) ELISA Kit

 
 

Jonlnbio Products Citations:

Article: Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia.
[JL13297] Rat Malondialdehyde(MDA) ELISA Kit [JL12296] Rat Creatine Kinase MB Lsoenzyme (CKMB) ELISA Kit [JL13014] Rat Cardiac Troponin Ⅰ (cTn-Ⅰ) ELISA Kit [JL22893] Rat Superoxide Dismutases (SOD) ELISA Kit	Rat	Military Medical Research	IF=16.7
Article: CXCL13 Damages Blood Spinal Cord Barrier by Promoting RNF6/Sqstm1-Ubiquitination Induced Autophagy in Experimental Allergic Encephalomyelitis.
[JL31030] Mouse B-Lymphocyte Chemoattractant 1 (BLC-1;CXCL13) ELISA Kit	Mouse	Advanced Science	IF=14.3
Article: Autophagy inhibition recovers deficient ICD-based cancer immunotherapy.
[JL11913] Mouse Granzyme B (Gzms-B) ELISA Kit [JL13702] Mouse High Mobility Group Protein B1 (HMGB-1) ELISA Kit	Mouse	Biomaterials	IF=12.8
Article: Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells.
[JL19939] Human Vascular Endothelial Growth Factor A (VEGF-A) ELISA Kit	Human	Journal of Experimental & Clinical Cancer Research	IF=11.4

 
 

References:

1. Glick D , Barth S , Macleod K F .Autophagy: cellular and molecular mechanisms[J].The Journal of Pathology, 2010, 221(1).DOI:10.1002/path.2697.
2. Parzych K R , Klionsky D J .An Overview of Autophagy: Morphology, Mechanism, and Regulation[J].Antioxidants & Redox Signaling, 2014, 20(3):460-473.DOI:10.1089/ars.2013.5371.
3. Jayanta D , Noor G , Kevin M. R .Autophagy and autophagy-related pathways in cancer[J].Nature reviews: molecular cell biology, 2023(8):24.DOI:10.1038/s41580-023-00585-z.
4. Wirawan E , Berghe T V , Lippens S ,et al.Autophagy: for better or for worse[J].Cell Research, 2012.DOI:10.1038/cr.2011.152.
5. Levine B , Kroemer G .Autophagy in the pathogenesis of disease.[J].Cell, 2008, 132(1):27-42.DOI:10.1016/j.cell.2007.12.018.